Glucotrack, Inc. current report, 31 October 2019

Business Context and Reporting Period

This Form 8-K is a current report filed by Integrity Applications, Inc. (not Glucotrack, Inc.) on November 6, 2019, covering events occurring on October 31, 2019. The registrant is a Delaware corporation with principal executive offices in Ashdod, Israel. The filing reports a corporate governance change involving the Board of Directors.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial statements or operational metrics.

Material Changes

The primary material change reported is the appointment of Allen E. Danzig to the Company's Board of Directors, effective October 31, 2019. Mr. Danzig was also appointed as Chair of the Nominating, Governance and Compensation Committee. He has been qualified as an independent director under Nasdaq rules.

Guidance, Outlook, and Management Commentary

The filing contains no financial guidance, outlook, or management commentary regarding future performance. It notes that Mr. Danzig will be compensated consistent with the Company's structure for non-employee directors. His background includes significant experience at L3Harris Technologies, Inc., Celanese Corporation, and The Hertz Corporation.

Investor Verification Checklist

  • Verify the correct registrant name is Integrity Applications, Inc., as the input metadata referenced Glucotrack, Inc.
  • Confirm the independence status of Allen E. Danzig under Nasdaq rules.
  • Review the Company's standard compensation structure for non-employee directors to understand the financial impact of this appointment.
  • Check for any subsequent filings regarding the composition of the Nominating, Governance and Compensation Committee.